Cyclic vomiting syndrome responding to amisulpride – A case report

Dramatic Improvement ◽

Triggering Factors ◽

Cyclic vomiting syndrome (CVS) is an uncommon functional condition defined by recurring episodic stereotyped vomiting with a sudden start and an unknown origin. CVS can be triggered by a variety of conditions, and the course and management are often determined by the triggering factors. We present the case of a 13-year-old female youngster who complained of frequent bouts of vomiting that coincided with the onset of menses. We started her on oral amisulpride 50 mg a few days before each menstrual period. As a result of the treatment, in the following menstrual cycle, she had a dramatic improvement in her symptoms.

Cyclic vomiting syndrome associated with benign paroxysmal vertigo: a case report

Acta Neurologica Belgica ◽

10.1007/s13760-019-01194-4 ◽

2019 ◽

Vol 120 (5) ◽

pp. 1207-1208

Author(s):

Sylvain Redon ◽

Maya Elzière ◽

Isabelle Lambert ◽

Anne Donnet

Keyword(s):

Case Report ◽

A case-report of migraine “sine headache”

Cephalalgia ◽

10.1177/0333102417690892 ◽

2017 ◽

Vol 38 (3) ◽

pp. 592-594

Author(s):

Arens Taga ◽

Marco Russo ◽

Antonio Genovese ◽

Gian Camillo Manzoni ◽

Paola Torelli

Keyword(s):

Case Report ◽

Female Patient ◽

Migraine Without Aura ◽

Nausea And Vomiting ◽

Full Spectrum ◽

Abdominal Migraine ◽

Associated Symptoms ◽

History Of ◽

Background and objectives We describe a case of a female patient whose otherwise “typical” migraine attacks turned into episodes with a full spectrum of associated symptoms but without headache. Case report We evaluated a 53-year-old woman with a long history of migraine without aura. In concomitance with premenopausal menstrual dysregulation, she reported episodes of nausea and vomiting, associated with photophobia, phonophobia and osmophobia, but without headache; these episodes were responsive to oral triptans. Alternative diagnoses were excluded through extensive examinations. Discussion To date, no reports have been published in the literature on otherwise typical migraine attacks that are not accompanied by headache, nor did our case seem comparable to cases of abdominal migraine and cyclic vomiting syndrome. Conclusion Pathophysiologically, we hypothesize that functional dysregulation of the hypothalamus-brainstem connectivity may generate migraine attacks with a full spectrum of associated symptoms but without pain.

Type 1 diabetes complicated with uncontrollable adult cyclic vomiting syndrome: a case report

Journal of Diabetes & Metabolic Disorders ◽

10.1186/s40200-015-0206-6 ◽

2015 ◽

Vol 14 (1) ◽

Cited By ~ 1

Author(s):

Kazuma Ogiso ◽

Nobuyuki Koriyama ◽

Ayako Akao ◽

Mayumi Otsuji ◽

Takahiko Goto ◽

...

Keyword(s):

Type 1 Diabetes ◽

Case Report ◽

A Case Report of Heterotopic Pancreas with Cyclic Vomiting Syndrome

Advances in Clinical Medicine ◽

10.12677/acm.2020.109316 ◽

2020 ◽

Vol 10 (09) ◽

pp. 2108-2111

Author(s):

洪亭鹿

Keyword(s):

Case Report ◽

Heterotopic Pancreas ◽

Erythromycin in therapy of cyclic vomiting syndrome

Srpski arhiv za celokupno lekarstvo ◽

10.2298/sarh0706339p ◽

2007 ◽

Vol 135 (5-6) ◽

pp. 339-341 ◽

Cited By ~ 1

Author(s):

Momcilo Pavlovic ◽

Nedeljko Radlovic ◽

Zoran Lekovic ◽

Karolina Berenji

Keyword(s):

Case Report ◽

Adverse Effects ◽

Unknown Aetiology ◽

Variable Success ◽

Erythromycin Therapy ◽

Cyclic vomiting syndrome is an insufficiently understood disorder which manifests itself in stereotypical episodes of vomiting with no detectable organic cause. Considering its unknown aetiology, drugs borrowed from various medication classes are applied in the therapy of this disorder, with variable success. Among other medicaments, erythromycin is also used in treatment of cyclic vomiting syndrome. This is a case study in which the application of erythromycin led to the prevention of attacks of cyclic vomiting syndrome. Our case report presents how periodical erythromycin therapy in two-week intervals at expected attack periods in a girl led to disappearance of cyclic vomiting. Adverse effects of erythromycin did not show up.